Open PHACTS Foundation

Monthly Archives: March 2016

Home »  2016 »  March

Webinar: SureChEMBL Patent Annotations in Open PHACTS

On March 21, 2016, Posted by , In Webinars, By ,,, , With Comments Off on Webinar: SureChEMBL Patent Annotations in Open PHACTS

George Papadatos (EMBL-EBI) gives an overview of the SureChEMBL data integration with the Open PHACTS Discovery Platform, focussing on practical details of use cases and business questions that can be answered with the combination of the Open PHACTS API and workflow tools. Watch webinar video | View webinar slides

Conference: 251st ACS National Meeting & Exposition

On March 17, 2016, Posted by , In Conferences, By ,,,,,,, , With Comments Off on Conference: 251st ACS National Meeting & Exposition

251st ACS National Meeting & Exposition, San Diego, USA Herman van Vlijmen (Janssen) gave a presentation: Open PHACTS: Semantic interoperability for drug discovery Valery Tkachenko (Royal Society of Chemistry) gave a presentation: Implementing chemistry platform for Open PHACTS: Lessons learned Anna Gaulton (EMBL-EBI) gave a presentation: Representation of drug discovery knowledge in the…

Presentation: Open PHACTS: Semantic interoperability for drug discovery

On March 17, 2016, Posted by , In Presentations, By ,,, , With Comments Off on Presentation: Open PHACTS: Semantic interoperability for drug discovery

251st ACS National Meeting & Exposition, San Diego, USA Herman van Vlijmen (Janssen) View presentation

Presentation: Implementing chemistry platform for Open PHACTS: Lessons learned

On March 17, 2016, Posted by , In Presentations, By ,,, , With Comments Off on Presentation: Implementing chemistry platform for Open PHACTS: Lessons learned

251st ACS National Meeting & Exposition, San Diego, USA Valery Tkachenko (Royal Society of Chemistry) View presentation

Presentation: Representation of drug discovery knowledge in the ChEMBL and SureChEMBL databases

On March 17, 2016, Posted by , In Presentations, By ,,, , With Comments Off on Presentation: Representation of drug discovery knowledge in the ChEMBL and SureChEMBL databases

251st ACS National Meeting & Exposition, San Diego, USA Anna Gaulton (EMBL-EBI) View presentation

Webinar: SureChEMBL Patent Annotations

On March 16, 2016, Posted by , In News, By ,,,,, , With Comments Off on Webinar: SureChEMBL Patent Annotations

Now that the Open PHACTS project is complete, we’re opening our regular discussions about using Open PHACTS for science up to the whole community, with a series of free monthly webinars. Our first webinar will be about SureChEMBL Patent Annotations, on Monday, 21 March at 15:00 GMT. Register now for…

Publication: The FAIR Guiding Principles for scientific data management and stewardship

There is an urgent need to improve the infrastructure supporting the reuse of scholarly data. A diverse set of stakeholders—representing academia, industry, funding agencies, and scholarly publishers—have come together to design and jointly endorse a concise and measureable set of principles that we refer to as the FAIR Data Principles….

Conference: RD-Connect Annual Meeting 2016

On March 11, 2016, Posted by , In Conferences, By ,,,, , With Comments Off on Conference: RD-Connect Annual Meeting 2016

RD-Connect Annual Meeting 2016, Barcelona, Spain Marco Roos (Leiden University Medical Center) held a training session, using Open PHACTS as paradigm for data linkage solutions and a source of drug compound information

Newsletter 9: What’s next for Open PHACTS?

On March 10, 2016, Posted by , In Newsletters, By ,,,,,,, , With Comments Off on Newsletter 9: What’s next for Open PHACTS?

Contents Project wrap-up Joining the Foundation Webinar series: Science and Open PHACTS Platform updates View newsletter Sign up for the Open PHACTS Newsletter

Conference: ELIXIR All Hands 2016

On March 7, 2016, Posted by , In Conferences, By ,,,,, , With Comments Off on Conference: ELIXIR All Hands 2016

ELIXIR All Hands 2016, Barcelona, Spain Marco Roos (Leiden University Medical Center) held a training session, using Open PHACTS as paradigm for data linkage solutions and a source of drug compound information